During the past decade, Ocular Therapeutix, Inc conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ocular Therapeutix, Inc" are "Ocular Hypertension" (2 trials), "Open Angle Glaucoma" (2 trials), "Cataract" (1 trials), "Dry Eye" (1 trials) and "Dry Eye Disease" (1 trials). Many other conditions were trialed in "Ocular Therapeutix, Inc" in a lesser frequency.

Most popular intervention types in "Ocular Therapeutix, Inc" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dextenza" (1 trials), "Durysta, Bimatoprost Intracameral Implant 10 µg" (1 trials), "OTX-CSI" (1 trials), "OTX-DED" (1 trials) and "OTX-TIC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ocular Therapeutix, Inc" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Ocular Therapeutix, Inc". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ocular Therapeutix, Inc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ocular Therapeutix, Inc, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".